Download PDF
Exp Clin Endocrinol Diabetes 2012; 120(09): 553-559
DOI: 10.1055/s-0032-1311644
Article
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

MiRNA-21 Reverses High Glucose and High Insulin Induced Insulin Resistance in 3T3-L1 Adipocytes through Targeting Phosphatase and Tensin Homologue

H.-y. Ling
1   Department of Physiology, School of Medicine, University of South China, Hengyang, China
2   Center for basic medical post-doctoral studies, University of South China, Hengyang, China
,
B. Hu
1   Department of Physiology, School of Medicine, University of South China, Hengyang, China
,
X.-b. Hu
3   Department of Biochemistry and Molecular Biology, School of life sciences and Technology, University of South China, Hengyang, China
,
J. Zhong
4   Institute of Clinical Research/First Affiliated Hospital, University of South China, Hengyang, China
,
S.-d. Feng
5   Department of Epidemiology, School of Public Health, University of South China, Hengyang, China
,
L. Qin
6   Key Laboratory for Pharmacoproteomics of Hunan Province/Institute of Pharmacy and Pharmacology, University of South China, Hengyang, China
,
G. Liu
6   Key Laboratory for Pharmacoproteomics of Hunan Province/Institute of Pharmacy and Pharmacology, University of South China, Hengyang, China
,
G.-b. Wen
4   Institute of Clinical Research/First Affiliated Hospital, University of South China, Hengyang, China
,
D.-f. Liao
7   Division of Stem Cell Regulation and Application, State Key Laboratory of Chinese Medicine Powder and Medicine Innovation in Hunan (incubation), Hunan University of Chinese Medicine, Changsha Hunan, China.
› Author Affiliations
Further Information

Publication History

received 20 November 2011
first decision 01 April 2012

accepted 02 April 2012

Publication Date:
06 September 2012 (online)

Also available at
   Permissions and Reprints

Abstract

Aims/hypothesis:

Our previous study showed there was a change of microRNA (miRNA) expression profile, and miR-21 was significantly down regulated in insulin-resistant adipocytes (IR-adipocytes). Phosphatase and tensin homologs deleted on chromosome 10 (PTEN), a negative regulator of the phosphatidylinositol 3-kinase (PI3K)/AKT pathway, was identified to be a target gene of miR-21, which suggested miR-21 might be associated with insulin resistance (IR) or diabetes. However, it is not known whether miR-21 play any role in the development of IR in 3T3-L1 adipocytes.

Methods:

Normal adipocytes and adipocytes transfected with pre-miR-21(pmiR-21) or negative control (pNeg) were treated with high glucose and high insulin for 24 h, insulin-stimulated glucose uptake was determined by 2-Deoxyglucose transport assay, miR-21 expression level was measured by using quantitative real-time RT-PCR (qRT-PCR). The protein expression levels of PTEN, Akt, phospho-Akt (Ser473), IRβ, GSK3β, phospho-GSK3β (Ser9) and GLUT4 were detected by western blotting assay.

Results:

We further confirmed that miR-21 was down regulated in IR-adipocytes by qRT-PCR. Over-expression of miR-21 significantly increased insulin-induced glucose uptake and decreased PTEN protein expression, while it had no significant effect on PTEN mRNA expression in IR-adipocytes. Moreover, over-expressing miR-21 significantly increased insulin-induced phosphorylation of AKT (Ser473), GSK3β (Ser9) and the translocation of glucose transporter 4 (GLUT4) in IR-adipocytes.

Conclusions:

In this study, our data demonstrate that miR-21 reverses high glucose and high insulin induced IR in 3T3-L1 adipocytes, possibly through modulating the PTEN-AKT pathway, and miR-21 may be a new therapeutic target for metabolic diseases such as T2DM and obesity.

Key words

miR-21 - insulin resistance - PTEN - AKT
 

  • References

  • 1 Bartel DP. MicroRNAs:genomics, biogenesis, mechanism, and function. Cell 2004; 116 (2) 281-297
    CrossrefPubMedGoogle Scholar
  • 2 Ambros V. The functions of animal microRNAs. Nature 2004; 431 (7006) 350-355
    CrossrefPubMedGoogle Scholar
  • 3 Teleman AA, Cohen SM. Drosophila lacking microRNA miR-278 are defective in energy homeostasis. Genes & Dev 2006; 20 (11) 417-422
    PubMedGoogle Scholar
  • 4 Poy MN, Spranger M, Stoffel M. MicroRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes Metab 2007; 9 (Suppl. 02) 67-73
    CrossrefPubMedGoogle Scholar
  • 5 Poy MN, Eliasson L, Krutzfeldt J et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004; 432 (7014) 226-230
    CrossrefPubMedGoogle Scholar
  • 6 Kloosterman WP, Lagendijk AK, Ketting RF et al. Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol 2007; 5 (8) e203
    CrossrefPubMedGoogle Scholar
  • 7 Sun TW, Fu MG, Bookout AL et al. MicroRNA let-7 regulates 3T3-L1 adipogenesis. Mol Endocrinol 2009; 23 (6) 925-931
    CrossrefPubMedGoogle Scholar
  • 8 Ling HY, Ou HS, Feng SD et al. Changes in microRNA profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clin Exp Pharmacol Physiol 2009; 38: e32-e39
    PubMedGoogle Scholar
  • 9 He A, Zhu L, Gupta N et al. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 2007; 21 (11) 2785-2794
    CrossrefPubMedGoogle Scholar
  • 10 Kim YJ, Hwang SJ, Bae YC et al. MiR-21 Regulates Adipogenic Differentiation through the Modulation of TGF-b Signaling in Mesenchymal Stem Cells Derived from Human Adipose Tissue. Stem Cells 2009; 27 (12) 3093-3102
    PubMedGoogle Scholar
  • 11 Dey N, Das F, Mariappanl MM et al. icroRNA-21 orchestrates high glucose-induced signals to TORC1 for renal cell pathology in diabetes. J Biol Chem 2011; 286 (6) 25586-25603
    CrossrefPubMedGoogle Scholar
  • 12 Zhang Z, Peng H, Chen J et al. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Letters 2009; 583 (45) 2009-2014
    CrossrefPubMedGoogle Scholar
  • 13 Roy S, Khanna S, Hussain SR et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase, tensin homologue. Cardiovasc Res 2009; 82 (1) 21-29
    CrossrefPubMedGoogle Scholar
  • 14 Iliopoulos D, Jaeger SA, Hirsch HA et al. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010; 39 (4) 493-506
    CrossrefPubMedGoogle Scholar
  • 15 Tang XQ, Powelka AM, Soriano NA et al. PTEN, but Not SHIP2, Suppresses Insulin Signaling through the Phosphatidylinositol 3-Kinase/Akt Pathway in 3T3-L1 Adipocytes. J Biol Chem 2005; 280 (23) 22523-22529
    CrossrefPubMedGoogle Scholar
  • 16 Nakashima N, Sharma PM, Imamura T et al. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem 2000; 275 (17) 12889-12895
    CrossrefPubMedGoogle Scholar
  • 17 Ling HY, Wen GB, Feng SD et al. MicroRNA-375 promotes 3T3-L1 adipocyte differentiation through modulation of extracellular signal-regulated kinase signaling. Clin Exp Pharmacol Physiol 2011; 38 (4) 239-246
    CrossrefPubMedGoogle Scholar
  • 18 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] method. Methods 2001; 25 (4) 402-408
    CrossrefPubMedGoogle Scholar
  • 19 Perrini S, Natalicchio A, Laviola L et al. Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane. Diabetes 2004; 53 (1) 41-52
    CrossrefPubMedGoogle Scholar
  • 20 Xiao J, Luo X, Lin H et al. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 2007; 282 (17) 12363-12367
    CrossrefPubMedGoogle Scholar
  • 21 Kato M, Zhang J, Wang M et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci 2007; 104 (9) 3432-3437
    CrossrefPubMedGoogle Scholar
  • 22 Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006; 7 (2) 85-96
    CrossrefPubMedGoogle Scholar
  • 23 Jiang G, Zhang BB. Pi3-kinase and its up- and down-stream modulators as potential targets for the treatment of type II diabetes. Front Biosci 2002; 7 (4) d903-d907
    CrossrefPubMedGoogle Scholar
  • 24 Shepherd PR, Kahn BB. Glucose transporters and insulin action- implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341 (4) 248-257
    CrossrefPubMedGoogle Scholar
  • 25 Van DE, Govers R, James DE. Akt activation is required at a late stage of insulin-induced GLUT4 translocation to the plasma membrane. Mol Endocrinol 2005; 19 (4) 1067-1077
    CrossrefPubMedGoogle Scholar